Travere Therapeutics (TVTX) Tax Provisions: 2013-2025
Historic Tax Provisions for Travere Therapeutics (TVTX) over the last 11 years, with Sep 2025 value amounting to $8,000.
- Travere Therapeutics' Tax Provisions rose 109.52% to $8,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5,000, marking a year-over-year decrease of 101.92%. This contributed to the annual value of $120,000 for FY2024, which is 46.19% down from last year.
- Latest data reveals that Travere Therapeutics reported Tax Provisions of $8,000 as of Q3 2025, which was down 60.00% from $20,000 recorded in Q2 2025.
- In the past 5 years, Travere Therapeutics' Tax Provisions registered a high of $313,000 during Q1 2021, and its lowest value of -$84,000 during Q3 2024.
- For the 3-year period, Travere Therapeutics' Tax Provisions averaged around $37,273, with its median value being $39,000 (2025).
- Its Tax Provisions has fluctuated over the past 5 years, first spiked by 1,475.00% in 2022, then plummeted by 800.00% in 2024.
- Quarterly analysis of 5 years shows Travere Therapeutics' Tax Provisions stood at $4,000 in 2021, then spiked by 1,475.00% to $63,000 in 2022, then rose by 7.94% to $68,000 in 2023, then tumbled by 205.88% to -$72,000 in 2024, then surged by 109.52% to $8,000 in 2025.
- Its Tax Provisions was $8,000 in Q3 2025, compared to $20,000 in Q2 2025 and $39,000 in Q1 2025.